-
EP2552414
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2552414
| EP2552414 - PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.06.2017 Database last updated on 19.07.2024 | |
| Former | Grant of patent is intended Status updated on 15.03.2017 | Most recent event Tooltip | 30.06.2017 | Application deemed to be withdrawn | published on 02.08.2017 [2017/31] | Applicant(s) | For all designated states Glenmark Pharmaceuticals Limited Glenmark House HDO-Corporate Bldg. Wing A, B.D. Sawant Marg Chakala, Andheri (East) Mumbai 400 099 / IN | [2013/06] | Inventor(s) | 01 /
DHUPPAD, Ulhas 3 Coral Park Shahu Nagar Motwani Factory Road Nashik Road 422 101 Nashik / IN | 02 /
CHAUDHARI, Sunil Sudhakar A-4 Pralhad Arcade Ashoka Marg Nashik Road Nashik 422 101 Maharastra / IN | [2013/06] | Representative(s) | HGF 1 City Walk Leeds LS11 9DX / GB | [N/P] |
| Former [2013/30] | Atkinson, Jonathan David Mark, et al Harrison Goddard Foote LLP Belgrave Hall Belgrave Street Leeds LS2 8DD / GB | ||
| Former [2013/06] | Harrison Goddard Foote Belgrave Hall Belgrave Street Leeds LS2 8DD / GB | Application number, filing date | 11762082.3 | 30.03.2011 | WO2011IB00674 | Priority number, date | IN2010MUM1082 | 31.03.2010 Original published format: IN 1082MU2010 | [2017/16] |
| Former [2013/06] | IN2010MUM1082 | 31.03.2010 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011121425 | Date: | 06.10.2011 | Language: | EN | [2011/40] | Type: | A1 Application with search report | No.: | EP2552414 | Date: | 06.02.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.10.2011 takes the place of the publication of the European patent application. | [2013/06] | Search report(s) | International search report - published on: | CN | 06.10.2011 | (Supplementary) European search report - dispatched on: | EP | 16.04.2014 | Classification | IPC: | A61K9/14, A61K9/72, A61P11/00, A61K9/16, A61K31/137, A61K31/167, A61K31/56 | [2014/20] | CPC: |
A61K31/137 (EP,US);
A61K31/167 (EP,US);
A61K31/56 (EP,US);
A61K45/06 (EP,US);
A61K9/0075 (EP,US);
A61K9/1623 (EP,US);
A61M11/003 (EP,US);
A61M15/0028 (EP,US);
A61P11/00 (EP);
A61P11/06 (EP);
A61P11/14 (EP);
A61P29/00 (EP);
A61M2202/064 (EP,US)
(-)
| C-Set: |
A61K31/137, A61K2300/00 (EP,US);
A61K31/56, A61K2300/00 (US,EP) |
| Former IPC [2013/06] | A61K9/14, A61K47/26, A61K9/72, A61M15/00, A61P11/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/06] | Title | German: | PHARMAZEUTISCHE PULVERZUSAMMENSETZUNG ZUR INHALATION | [2013/06] | English: | PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION | [2013/06] | French: | COMPOSITION DE POUDRE PHARMACEUTIQUE POUR INHALATION | [2013/06] | Entry into regional phase | 08.10.2012 | National basic fee paid | 08.10.2012 | Search fee paid | 08.10.2012 | Designation fee(s) paid | 08.10.2012 | Examination fee paid | Examination procedure | 08.10.2012 | Examination requested [2013/06] | 05.11.2014 | Amendment by applicant (claims and/or description) | 27.09.2016 | Communication of intention to grant the patent | 08.02.2017 | Application deemed to be withdrawn, date of legal effect [2017/31] | 16.03.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2017/31] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.09.2016 | Fees paid | Renewal fee | 22.02.2013 | Renewal fee patent year 03 | 04.02.2014 | Renewal fee patent year 04 | 22.01.2015 | Renewal fee patent year 05 | 09.03.2016 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.03.2017 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2007117661 (TEVA PHARMA [IL], et al) [X] 1-15 * examples 8,9 *; | [X]US2005158248 (ZENG XIAN-MING [GB]) [X] 1-14 * example -; tables 3,4 *; | [XP]EP2172190 (LICONSA LABORATORIOS SA [ES]) [XP] 1-15 * paragraphs [0044] , [0050] - [0053] - [0081] - [0083]; example -; table 3 *; | [A]WO2010014827 (STC UNM [US], et al) [A] 1-15 * paragraphs [0012] - [0016] * | International search | [A]CN1805731 (VECTURA LTD [GB]); | [A]CN101111226 (MEDERIO AG [CH]); | [A]CN1964700 (VECTURA LTD [GB]); | [A]CN101032484 (NANJING KANGZE PHARMACEUTICAL [CN]); | [A]US5478578 (ARNOLD KLAUS [DE], et al) |